Current and Future Cardiovascular PET Radiopharmaceuticals

被引：2
|
作者：
Al-Haddad, Rami [1 ]
Ismailani, Uzair S. [1 ]
Rotstein, Benjamin H. [1 ]
机构：
[1] Univ Ottawa, Univ Ottawa Heart Inst, Dept Biochem Microbiol & Immunol, 40 Ruskin St, Ottawa, ON K1Y 4E9, Canada
来源：
PET CLINICS | 2019年 / 14卷 / 02期
关键词：
Cardiovascular diseases; Positron emission tomography imaging; Radiotracers; Myocardial blood flow; Atherosclerosis; Fatty acid metabolism; Cardiac autonomic nervous system; MYOCARDIAL BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; MATRIX-METALLOPROTEINASE ACTIVITY; ATHEROSCLEROTIC PLAQUES; N-13; AMMONIA; NONINVASIVE QUANTIFICATION; IMAGING ATHEROSCLEROSIS; VASCULAR INFLAMMATION; PERFUSION; DISEASE;
D O I：
10.1016/j.cpet.2018.12.010
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PET imaging is a continuously developing clinical tool for the imaging of different markers of cardiovascular diseases. In this article, some important PET tracers for several diseases affecting the heart and the vessels are highlighted; these include myocardial blood flow, atherosclerosis, fatty acid metabolism, and pathologies in the cardiac autonomic nervous system.
引用
收藏
页码：293 / +
页数：14
相关论文
共 50 条
  • [1] Present and future of PET-radiopharmaceuticals
    Elsinga, Philip H.
    [J]. NUCLEAR MEDICINE REVIEW, 2012, 15 : C13 - C16
  • [2] PET Oncological Radiopharmaceuticals: Current Status and Perspectives
    Lin, Mai
    Coll, Ryan P.
    Cohen, Allison S.
    Georgiou, Dimitra K.
    Manning, Henry Charles
    [J]. MOLECULES, 2022, 27 (20):
  • [3] PET/MR Imaging Current and Future Applications for Cardiovascular Disease
    Naeger, David M.
    Behr, Spencer C.
    [J]. MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2015, 23 (01) : 95 - +
  • [4] Challenges, Current Status, and Future Utility of PET in Cardiovascular Disorders
    Rojulpote, Chaitanya
    Patil, Shivaraj
    Gonuguntla, Karthik
    Zhang, Vincent
    Borja, Austin
    Narayanareddy, Pranathi
    Hancin, Emily
    Revheim, Mona-Elisabeth
    Werner, Thomas
    Alavi, Abass
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [5] Novel Radiopharmaceuticals in Cardiovascular Medicine: Present and Future
    Iqbal, Basit
    Currie, Geoffrey
    Greene, Lacey
    Kiat, Hosen
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2014, 45 (04) : 423 - 434
  • [6] Non-FDG Radiopharmaceuticals in Head and Neck PET Imaging: Current Techniques and Future Directions
    Eisenmenger, Laura B.
    [J]. SEMINARS IN ULTRASOUND CT AND MRI, 2019, 40 (05) : 424 - 433
  • [7] PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape
    Uzuegbunam, Bright Chukwunwike
    Librizzi, Damiano
    Yousefi, Behrooz Hooshyar
    [J]. MOLECULES, 2020, 25 (04):
  • [8] New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
    Sogbein, Oyebola O.
    Pelletier-Galarneau, Matthieu
    Schindler, Thomas H.
    Wei, Lihui
    Wells, R. Glenn
    Ruddy, Terrence D.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [9] Current and novel radiopharmaceuticals for imaging cardiovascular inflammation
    Heo, Gyu Seong
    Sultan, Deborah
    Liu, Yongjian
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (01): : 4 - 20
  • [10] PET radiopharmaceuticals: State-of-the-art and future prospects
    Tewson, TJ
    Krohn, KA
    [J]. SEMINARS IN NUCLEAR MEDICINE, 1998, 28 (03) : 221 - 234
12345